Inhibin A
Inhibins are heterodimeric glycoprotein hormones secreted by the granulosa cells of the ovary in females and the Sertoli cells in the male testis. Inhibins selectively suppress the secretion of follicle stimulating hormone (FSH) from the pituitary gland and have also been shown to have local action within the gonads.
Inhibin is a 32-kDalton protein consisting of α and ΒA protein chains that are covalently joined by disulfide bonds. A bimodal increase of serum inhibin-A concentration is typically observed during normal pregnancy. Concentrations increase during the first trimester, decline after ten weeks, remain stable between 15-25 weeks of gestation and then again increases, peaking at term. Total Inhibin A concentration is typically elevated if the fetus is affected by Down syndrome. Concentration may also be affected by gestational age, maternal weight, the number of fetuses, and preeclampsia.
Inhibin-A has also been reported to have clinical application as an adjunct to monitoring of ovarian granulosa cell tumors and mucinous epithelial neoplasms, as well as in reproductive physiology.
The inhibin-A assay utilizes a pair of highly characterized monoclonal antibodies in a two-site immunoassay that essentially eliminates the interference of inactive free α-monomer.
- As an aid in the diagnosis and monitoring of various hormonal reproductive disorders
- As an aid during the second trimester as part of the maternal serum quadruple screen
- As an aid in the diagnosis of preeclamptic toxemia
- As an aid in the diagnosis of ovarian (granulosa cell) tumors
- Aids evalation of ovarian mucinous epithelial tumors
- Though not cleared for use, published studies suggest Inhibin-A may have clinical application as an adjunct to the monitoring of ovarian granulosa cell tumors, as well as in reproductive physiology
Increased in:
- Pregnancy with gestational age
- Ovarian granulosa cell tumors and some mucinous epithelial neoplasms
- Some Preeclampsia
Units: pg/mL
| Group | pg/mL |
| Adult Males | 1.0–3.6 |
| Nonpregnant Adult Females | |
| Physiologic State | pg/mL |
| early follicular phase | 5.5–28.2 |
| Mid follicular phase | 7.9–34.5 |
| Late follicular phase | 19.5–102.3 |
| Mid cycle | 49.9–155.5 |
| Early luteal phase | 35.9–132.7 |
| Mid luteal phase | 13.2–159.6 |
| Late luteal phase | 7.3–89.9 |
| IVF – peak levels | 354.2–1690.0 |
| PCOS – ovulatory | 5.7–16.0 |
| Postmenopausal | 1.0–3.9 |
Electrochemiluminescence immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- J Obstet Gynaecol Res. 2011 Oct;37(10):1290-6. [PMID: 21535305]
- Adv Clin Chem. 2008; 45:1-29. [PMID: 18429491]
- J Clin Endocrinol Metab. 2007 Jul;92(7):2526-31 [PMID: 17473066]
- Reprod Biomed Online. 2005 Jun;10(6):786-812. [PMID: 15970011]